Teva says its generic Adderall shortage will last another 2 to 3 months (NYSE:TEVA) | Seeking Alpha
Ex-Teva Chairman, Blockchain Investor Accused of Pump-and-Dump Scheme - WSJ
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits - Bloomberg
Teva Pharmaceuticals - Wikipedia
Teva Gets Fresh Cash, Fresh Woes | Ctech
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva to lay off 25% of workforce, suspends dividend - BNN Bloomberg
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Considering Cutting up to 10,000 Jobs: Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT
Teva Pharmaceuticals Names Kare Schultz As New CEO | Fortune
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva: Now What? | Barron's
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Justice Dept reportedly may file charges in its generic-drug probe by year-end
With New Teva Deal, Combined NY Settlements With Opioid Makers Top $2 Billion | New York Law Journal
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
